Loss of heterozygosity at chromosome 1p in different solid human tumours: Association with survival

British Journal of Cancer

Volumn 79, Issue 9-10, 1999, Pages 1468-1474

  Ragnarsson, G ^a   Eiriksdottir, G ^a   Johannsdottir, J Th ^a   Jonasson, J G ^a   Egilsson, V ^a   Ingvarsson, S ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Cancer; Chromosome 1p; Loss of heterozygosity; Survival statistics; Tumour suppressor gene

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; BREAST CANCER; CANCER SURVIVAL; CHROMOSOME 1P; COLON CANCER; ENDOMETRIUM CANCER; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KIDNEY CANCER; LUNG CANCER; MULTIVARIATE ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; SARCOMA; SOLID TUMOR; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; TUMOR SUPPRESSOR GENE;

EID: 0033046644     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690234     Document Type: Article

References (53)

1. Arlt MF, Herzog TJ, Mutch DG, Gersell DJ, Liu H and Goodfellow PJ (1996) Frequent deletions of chromosome 1p sequences of aggressive histologic subtype of endometrial cancer. Hum Mol Genet 5: 1017-1021
2. Bardi G, Pandis N, Fenger C, Kronborg O, Bomme L and Heim S (1993) Deletion of 1p36 as primary chromosomal aberration in intestinal tumorigenesis. Cancer Res 53: 1895-1898
3. Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestana A and Rey JA (1994) Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosom Cancer 9: 296-298
4. Bieche I, Champème MH and Lidereau R (1994) A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer. Cancer Res 54: 4274-4276
5. Bodmer JL, Burns K, Sneider P, Hofmann K, Steiner V, Thorne M, Bornand T, Hahne M, Schroter M, Becker K, Wilson A, French LE, Browning JL, MacDonald HR and Tschopp J (1997) Tramp, a novel apotosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6: 79-88
6. Buyse IM, Takahashi EI and Huang S (1996) Physical mapping of retinoblastoma interacting zinc finger gene RIZ to DIS228 on chromosome 1p36. Genomics 15: 119-121
7. Caron H, Peter M, van Sluis P, Speleman F, de Kraker J, Laureys G, Michon J, Brugieres L, Voute PA, Westerveld A, Slater R, Delattre O and Versteeg R (1995) Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum Mol Genet 4: 535-539
8. Caron H, van Sluis P, de Kraker J, Bokkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voute PA and Versteeg R (1996) Allelic loss of chromosome 1p as a predictor of unfavourable outcome in patients with neuroblastoma. N Engl J Med 334: 225-230
9. Cavenee WK and White RL (1995) The genetic basis of cancer. An accumulation of genetic defects can apparently cause normal cells to become cancerous and cancerous cells to become increasingly dangerous. Sci Am (March) 72-79
10. Chase PB, Yang JM, Thompson FH, Halonen M and Regan JW (1996) Regional mapping of the platelet-activating factor receptor gene (PTAFR) to 1p35-p34.3 by fluorescence in situ hybridisation. Cytogenet Cell Genet 72: 205-207
11. Chen LC, Kurisu W, Ljung BM, Goldman ES, Moore D II and Smith HS (1992) Heterogeneity for allelic loss in human breast cancer. J Natl Cancer Inst 84: 506-510
12. Cox DR (1972) Regression models and life-tables. J R Stat Soc (B) 34: 187-220
13. Di Vinci A, Infusini E, Peveri C, Risio C, Rossini FP and Giaretti W (1996) Deletions at chromosome 1p by fluorescence in situ hybridisation arc an early event in human colorectal tumorigenesis. Gastroenterology 111: 102-107
14. Dracopoli NC, Harnett P, Bale SJ, Stanger BZ, Tucker MA, Housman DE and Kefford RF (1989) Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA 86: 4614-4618
15. Duncan AMV, Anderson LL, Funk CD, Abramovitz M and Adam M (1995) Chromosomal localisation of the prostanoid receptor gene family. Genomics 25: 740-742
16. Ezaki T, Yanagisawa A, Otha K, Aiso S, Watanabe M, Hibi T, Kato Y, Nakajima T, Ariyama T, Inazawa J, Nakamura Y and Horii A (1996) Deletions mapping on chromosome 1p in well-differentiated gastric cancer. Br J Cancer 73: 424-428
17. Haber D and Harlow E (1997) Tumor-suppressor genes: evolving definitions in the genomic age. Nat Genet 16: 320-322
18. Hey Y, Hoggard N, Brintnell B, James L, Jones D, Mitchell E, Weissenbach J and Varley JM (1996) Identification and cloning in yeast artificial chromosomes of a region of elevated loss of heterozygosity on chromosome 1p31.1 in human breast cancer. Cytogenet Cell Genet 72: 148
19. Johnson DW, Qumsiyeh M and Benkhalifa M (1995) Assignment of human transforming growth factor-beta type I and type III receptor genes (TGFRBR1 and TGFBR3) to 9q33-q34 and 1p32-p33, respectively. Genomics 28: 356-357
20. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F and Caput D (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809-819
21. Kaplan EL and Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
22. Kemper O, Derre J, Cherif D, Engelmann H, Wallach D and Berger R (1991) The gene for the type II (p75) tumor necrosis factor receptor (TNF-RII) is localized on hand 1p36.2-p36.3. Hum Genet 87: 623-624
23. Kuroki T, Fujiwara Y, Tsuchiya E, Nakamori S, Imaoka S, Kanematsu T and Nakamura Y (1995) Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity of chromosome arm 1p occurs at an early stage of hepatocarcinogenesis. Genes Chromosom Cancer 13: 163-167
24. Kwon BS, Tan KB, Ni J, Lee KO, Kim KK, Kim YJ, Wang S, Gentz R, Yu GL, Harrop J, Lyn SD, Silverman C, Porter TG, Truneh A and Young PR (1997) A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem 272: 14272-14276
25. Lahti JM, Valentine M, Xiang J, Jones B, Amann J, Grenet J, Richmond G, Look AT and Kidd VJ (1994) Alteration in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma. Nat Genet 7: 370-375
26. Lapointe J, Lachance Y and Labrie C (1996) A p18 mutant defective in cdk6 binding in human breast cancer cells. Cancer Res 56: 4586-4589
27. Lees JA, Saito M, Vidal M, Valentine M, Look T, Harlow E, Dyson N and Helin K (1993) The retinoblastoma protein binds to a family of E2F transcriptional factors. Mol Cell Biol 13: 7813-7825
28. Mantel N (1960) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170
29. Mathew CGP, Smith BA, Thorpe K, Wong Z, Royle NJ, Jeffreys AJ and Ponder BAJ (1987) Deletion of genes on chromosome 1 in endocrine neoplasia. Nature 328: 524-526
30. Mathew S, Murty VV, Bosl GJ and Chaganti RS (1994) Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors. Cancer Res 54: 6265-6269
31. Miller SA, Dykes DD and Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16: 1215
32. Modi WS, Farrar WL and Howard OMZ (1995) Confirmed assignment of a novel human tyrosine kinase gene (JAK1A) to 1p32.3-31.3 by non isotopic in situ hybridization. Cytogenet Cell Genet 69: 232-234
33. Munn KE, Walker RA and Varley JM (1995) Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast. Oncogene 10: 1653-1657
34. Ogunbiyi OA, Goodfellow PJ, Gagliardi G, Swanson PE, Birnbaum EH, Fleshman JW, Kodner IJ and Moley JF (1997) Prognostic value of chromosome 1p allelic loss in colon cancer. Gastroenterology 113: 761-766
35. Ozawa K, Dean FB, Chen M, Lee SH, Shiratori A. Murakami Y, Sakura T, Hurwitz J and Eki T (1993) Mapping of the 70 kDa, 34 kDa, and a 11kDa subunit of the human multimeric single-stranded DNA binding protein /hSSB/RPA) to chromosome bands 17p13, 1p35-p36.1, and 7p21-p22. Cell Struct Funct 18: 221-230
36. 2 (PLA2S-II), maps to 1p35-36.1/DIS199. Cancer Res 55: 5504-5506
37. Ragnarsson G, Sigurdsson A, Eiriksdottir G, Barkardottir RB, Jonasson JG and Ingvarsson S (1996) Loss of heterozygosity at chromosomes 1p in human breast cancer - association with high S-phase, reduced patients survival, and deletions at other chromosome regions. Int J Oncol 9: 731-736
38. Rasio D, Murakumo Y, Robbins D, Roth T, Silver A, Negrini M, Schmidt C, Burczak J, Fishel R and Croce CM (1997) Characterisation of the human homologue of RAD54 - a gene located on chromosome 1p32 at a region of high loss of heterozygosity in breast tumors. Cancer Res 57: 2378-2383
39. Saito T, Seki N, Matsuda Y, Kitahara M, Murata M, Kanda N, Nomura N, Yamamoto T and Hori TA (1995) Identification of the human ERK gene as a putative receptor tyrosine kinase and its chromosomal localisation to 1p36.1: a comparative mapping of human, mouse, and rat chromosomes. Genomic 26: 382-384
40. Smith SA, Easton DF, Evans DG and Ponder BA (1992) Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nature Genet 2: 128-131
41. Speleman F, Van Camp G and Van Roy N (1996) Reassignment of MYCL1 to human chromosome 1p34.3 by fluoresence in situ hybridization. Cytogenet Cell Genet 72: 189-190
42. Steenman M, Redeker B, de Meulemeester M, Wiesmeijer K, Voute PA, Westerveld A, Slater R and Mannens M (1997) Comparative genomic hybridization analysis of Wilms tumor. Cytogenet Cell Genet 77: 296-303
43. Stock C, Ambros IM, Lion T, Haas OA, Zoubek A, Gadner H and Ambros PF (1994) Detection of numerical and stuctural chromosome abnormalities in paediatric germ cell tumors by means of interphase cytogenetics. Genes Chromosomes Cancer 11: 40-50
44. Sulman EP, Tang XX, Allen C, Biegel JA, Pleasure DF, Brodeur GM and Ikegaki N (1997) ECK, a human EPH-related gene maps to 1p36.1, a common region of alteration in human cancer. Genomics 40: 371-374
45. Taguchi T, Jhanwar SC, Siegfried JM, Keller SM and Testa JR (1993) Recurrent deletions of specific chromosomal sites in 1p, 3p. 6q and 9p in human malignant mesothelioma. Cancer Res 53: 4349-4355
46. Tanaka K, Yanoshita R, Konishi M, Oshimura M, Maeda Y, Mori T and Miyaki M (1993) Suppression of tumorigenicity in human colon carcinoma cell by introduction of normal chromosome 1p36 region. Oncogene 8: 2253-2258
47. Vargas MP, Zhuang Z, Wang C, Vortmeyer A, Linehan WM and Merino MJ (1997) Loss of heterozygosity on the short arm of chromosomes 1 and 3 in sporadic pheochromocytoma and extra-adrenal paraganglioma. Hum Pathol 28: 411-415
48. Volpi EV, Romani M and Siniscalco M (1994) Subregional mapping of the human lymphocyte-specific protein tyrosine kinase gene (LCK) to 1p35-p34.3 and its position relative to the 1p marker DIS57. Cytogenet Cell Genet 67: 187-189
49. Vorobyov E, Mertsalov I, Dockhorn-Dwoeniczak B, Dwoeniczak B and Horst J (1997) The genomic organization and the full coding region of the human PAX7 gene. Genomics 45: 168-174
50. White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hilliard C, Valentine MB, Look AT, Enomoto H, Sakiyama S and Brodeur GM (1995) A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA 92: 5520-5524
51. Wu GS, Burns TF, McDonald ER, Jiang W, Meng R, Krantz ID, Kao G, Gan DD, Zhou JY, Muchel R, Hamilton SR, Spinner NB, Markowitz S, Wu G and el-Deiry WS (1997) Killer/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 17: 141-143
52. Yamamoto K, Kobayashi H, Miura O, Hirosawa S and Miyasaka N (1997) Assignment of IL12RB1 and IL12RB2, interleukin-12 receptor beta1 and beta2 chains, to human chromosome 19 band p13.1 and chromosome 1 band p31.2, respectively, by in situ hybridization. Cytogenet Cell Genet 77: 257-258
53. Yeh SH, Chen PJ, Chen HL, Lai MY, Wang CC and Chen DS (1994) Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res 54:4188-4192